Roche acquires Warburg-backed Constitution Medical Investors for $220m

34

blood cells_sqBuyout major Warburg Pincus has exited its investment in Constitution Medical Investors (CMI) by selling it to Swiss drugmaker Roche in a deal that valued the business at $220m.

CMI develops haematology testing system, which is designed to provide faster and more accurate diagnosis of blood-related diseases to improve patient care. The company was created and funded by Warburg and members of its management team.

In addition to the $220m upfront payment, Roche could be due further milestone dependent payments.

Last month it was reported that Warburg and Blackstone submitted second round bids for fellow buyout firm Carlyle’s aerospace communications firm Arinc.

Copyright © 2013 AltAssets